from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3238c/-

LFCtreatmentdescriptionclass of inhibitor

-1.405

Amikacinug/mL Amikacintranslation

-0.496

Cap5-10ug/mL Capreomycintranslation

-0.531

Rox10-50 ug/mL Roxithromycintranslation

-1.262

SM2-5 ug/mL Streptomycintranslation

-1.226

Tet5-10 ug/mL Tetracyclinetranslation

-0.061

Rif0.2-5ug/mL Rifampicintranscription

-0.366

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.211

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.102

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.488

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.726

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.060

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.846

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.803

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.680

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.564

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.054

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.398

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.186

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.307

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.135

KCN5-20 ug/mL Potassium cyaniderespiration

-0.483

NaN30.2-2 mM Sodium aziderespiration

-0.180

Nigericin50 uM Nigericinrespiration

1.492

TRC10-150 ug/mL Triclosanrespiration

1.737

TRZ10-25 ug/mL Thioridazinerespiration

0.093

Valinomycin0.5-10 uM Valinomycinrespiration

-2.024

ZnSO42 mM ZnSO4respiration

0.660

menadione6-10 ug/mL Menadionerespiration

-0.041

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.600

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.263

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.679

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.742

NRP_1Non-replicating persistence stage 1dosRassociated

-0.457

Amp0.2mg/mL AmpicillincellWall

-0.417

Cephalexin20-100 ug/mL CephalexincellWall

-0.898

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.338

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.351

EMB10-20 ug/mL EthambutolcellWall

-1.745

Eta12-40 ug/mL EthionamidecellWall

-1.641

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.340

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.312

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.527

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.358

BZA0.12 mg/mL BenzamidearomaticAmides

0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.105

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.765

H2O24 mM hydrogen peroxideDNAdamaging

-0.317

Levo10 ug/mL LevofloxacinDNAdamaging

0.276

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.656

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.355

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.225

UVUV-irradiationDNAdamaging

0.880

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.126

Antimycin12.5-50 ug/mL Antimycin A?

-0.716

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.009

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.232

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.180

PA8240.2-2 ug/mL PA-824?

0.025

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.041

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.225

Verapamil50 uM Verapamil?

0.017

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.529

methoxatin10-20 ug/mL Methoxatin?